Inspire Medical SystemsINSP
About: Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Employees: 1,246
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
500% more funds holding in top 10
Funds holding in top 10: 1 [Q2] → 6 (+5) [Q3]
63% more capital invested
Capital invested by funds: $4.38B [Q2] → $7.13B (+$2.75B) [Q3]
42% more first-time investments, than exits
New positions opened: 78 | Existing positions closed: 55
6% more funds holding
Funds holding: 323 [Q2] → 342 (+19) [Q3]
3.26% more ownership
Funds ownership: 110.11% [Q2] → 113.36% (+3.26%) [Q3]
3% more repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 110
9% less call options, than puts
Call options by funds: $121M | Put options by funds: $132M
Research analyst outlook
9 Wall Street Analysts provided 1 year price targets over the past 3 months
9 analyst ratings
Truist Securities Richard Newitter 74% 1-year accuracy 31 / 42 met price target | 27%upside $235 | Buy Maintained | 11 Feb 2025 |
RBC Capital Shagun Singh 61% 1-year accuracy 41 / 67 met price target | 40%upside $260 | Outperform Reiterated | 11 Feb 2025 |
Baird Mike Polark 73% 1-year accuracy 8 / 11 met price target | 34%upside $248 | Outperform Maintained | 11 Feb 2025 |
Wells Fargo Larry Biegelsen 63% 1-year accuracy 30 / 48 met price target | 5%upside $195 | Equal-Weight Maintained | 11 Feb 2025 |
Morgan Stanley Kallum Titchmarsh 67% 1-year accuracy 2 / 3 met price target | 19%upside $220 | Overweight Maintained | 11 Feb 2025 |
Financial journalist opinion
Based on 11 articles about INSP published over the past 30 days









